Erbitux in Combination With Xeloda and Cisplatin in Advanced Esophago-gastric Cancer

NCT00678535 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

904

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Cetuximab
DRUG: Capecitabine
DRUG: Cisplatin

Sponsor

Merck KGaA, Darmstadt, Germany